This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - FrançiasSearch

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page
Cancer TypesBreast CancerLung CancerMultiple MyelomaLeukaemiaKidney CancerCancer Insights PanelIntroducing the Cancer Insights PanelConfidence in the Healthcare SystemHCP-Patient RelationshipsAccess to Reliable InformationFamily, Friends and CaregiversMental HealthWellbeingAboutOur PurposePipelineCommitment

Menu

Close

Wellbeing 

The Cancer Insights Panel* highlighted patient wellbeing as a potential area of improvement during, and after, an experience of cancer. Commenting on their own experiences and the experiences of people they know that have been affected by cancer, the key themes relating to wellbeing were:1

Nutritional and physical wellbeing
Complementary wellbeing

Below are the panel members’ insights regarding wellbeing during an experience of cancer and their asks moving forward.

Hear from Helen who believes that, with the right support, people living with cancer can live some of their best days

Nutritional and physical wellbeing 

What the panel members said…1

What patients are asking for…1

  • “[Would like] access to trustworthy integrative medicine support – i.e. vitamins and diet. Everything I read is contradictory and you don’t know if you are doing the right thing or not.” – patient, metastatic breast cancer
  • “Many people feel the medical system didn’t provide any support for patients going through treatment recovery. Little to no advice is given on key areas: diet, exercise, retraining the bowel, reducing treatment side effects, preventing late effects.” – patient, colorectal cancer
  • “I found the exercise classes wonderful from both a physical and social point of view. They weren’t really advertised enough.” – patient, colorectal cancer
  • “A whole treatment plan should include: mental health support, nutrition and diet, exercise, wellbeing. The body and mind needs to be treated, not just the cancer.” – patient, metastatic breast cancer
Dietary and nutritional advice to be embedded in the treatment and recovery plan
  • Many panel members reported gaps in non-clinical cancer care in terms of nutritional and dietary advice, with many patients expressing eagerness to learn more about how their diet and nutritional intake can support them through their experience with cancer.  
Exercise and physical wellbeing to be embedded in the treatment and recovery plan
  • Some of the panel members shared desire from patients to learn more about exercise and physical recovery support after a diagnosis of cancer. The panel members highlighted a need for more information surrounding exercises and physical activities that may support and aid their recovery and ability to perform day-to-day tasks.
  • The panel members also recognised the importance of cancer-specific information, as some people have adjusted physical abilities after a particular type of cancer or treatment.

Complementary wellbeing

What the panel members said…1

What patients are asking for…1

  • “[HCPs should] consider holistic services – acupuncture, complementary therapy, yoga, pilates.’ – anonymous  
  • “Different trusts offer therapies such as reflexology and acupuncture – but these are limited to 6-10 sessions.” – anonymous   
  • “Consider holistic services – acupuncture, complementary therapy, yoga, pilates.” – anonymous
Complementary therapies to be discussed as appropriate 
  • For some patients, complementary therapies are an important pillar of cancer management. Although these are not a replacement for traditional medicine, the panel members noted a need for alternative therapies to be better signposted and offered to patients where appropriate – for example, as a means of dealing with certain symptoms or to boost their physical or emotional health. 
  • With this information provided by HCPs, the hope is that patients are more likely to come across reputable information on complementary therapies (and avoid information on unfounded information, such as alternative therapies). 
Wellbeing (PDF download)

Download a one-page summary of the Cancer Insights Panel's commentary and key takeaways surrounding wellbeing during an experience of cancer 

 Download PDFLoading

Explore More

HCP-Patient Relationships

Insights surrounding HCP-patient relationships during an experience of cancer

Read MoreLoading Access to Reliable Information 

Insights surrounding patients' access to reliable information during an experience of cancer

Read MoreLoadingCancer Insights Panel

*The Cancer Insights Panel is a Pfizer initiative developed to gather the perspectives of people impacted by cancer. The first panel, which ran between June 2022 and January 2024, was formed of 30 people who were carefully selected based on their ability to share the needs and voices of a range of people affected by cancer, including patients and carers alike. This resource has been developed based on insights shared by panel members. Pfizer has reviewed and compiled these insights, to identify potential areas for improvement during an experience of cancer. All panel members have consented to the sharing of their contributions. Direct quotes from panel members are presented in quotation marks.

Reference: 

Pfizer Ltd. Data on file. REF-UNP26999.
PP-UNP-GBR-8443. October 2024

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024.

YesNo
You are now leaving PfizerPro​​​​​
​
You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​